Svmuu News The UK government has announced it is abandoning a previous proposal that would have allowed AI companies to use copyrighted content for model training by default under an "opt-out" premise. This proposal had sparked widespread opposition, including from figures like Elton John, Dua Lipa, and the UK House of Lords.
UK Technology Minister Liz Kendall stated that the government has listened to all parties and will not proceed with the proposal. A concurrently released report pointed out that there is still no consensus across sectors on how to balance creators' rights with the development of the AI industry. Tom Kiehl, CEO of UK Music, called this move a "major victory."
However, the UK government has not yet proposed an alternative plan and has stated that it will not adjust current copyright laws until it is confirmed that reforms can achieve economic and social goals. Technology industry groups are concerned that a prolonged lack of clear rules could weaken the UK's position in global competition. (BBC)
UK Government Withdraws AI Copyright Default Use Proposal, Creators Hail Major Victory
Source:Odaily · Source Link
Disclaimer: This content reflects only the author’s personal views and does not constitute any investment or financial advice. If you discover any content that violates regulations,Click to Report
24H Trending
-
1
Billionaire investor Chase Coleman’s Tiger Global fund disclosed in its latest 13F filing that its top five growth stocks are all focused on AI infrastructure, including TSMC, NVIDIA, Amazon, Meta, and Google.
-
2
Will the BEAM token go to zero? Could it rise to $1,000? An in-depth analysis of the Beam network and its market prospects
-
3
Analysis of CRYSTAL’s Value and Investment Potential: An Examination of Multiple Projects and Risk Assessment
-
4
What Is CVP? An In-Depth Analysis of the PowerPool Ecosystem and the Investment Value of Its Token, CVP
-
5
Analysis: The State Street Healthcare ETF (XLV) has an expense ratio of 0.08% and a diversified portfolio, while the Invesco Biotechnology ETF (PBE) has an expense ratio of 0.58% and focuses on small-cap stocks; PBE is up 10.2% year-to-date, outperforming XLV.
-
6
QUARTZ Coin Analysis: An Overview of the Sandclock (QUARTZ) and Unique Network’s Quartz (QTZ) Projects
-
7
Ethereum Recent Rebound: Price Breaks Above $1,970, but Multiple Risks Remain
-
8
MARA Stock Valuation Analysis: Marathon Digital Holdings’ Transition to AI and Long-Term Investment Outlook
-
9
What Is JGN? Analysis of the JGN (Sword Saint Coin) Project’s Positioning, Features, and Value
-
10
NVIDIA and AMD: The Two Giants of AI Computing Power in 2026—An Analysis of Market Dynamics, Financial Performance, and Opportunities for Transition into Cryptocurrency Mining
Markets Today
Recommended Reading










